A carregar...
Evidence for the efficacy and safety of anti-interleukin-5 treatment in the management of refractory eosinophilic asthma
Two recent phase III trials in patients with severe eosinophilic asthma have shown that anti-interleukin 5 (IL-5) therapy with mepolizumab reduces the frequency of asthma attacks, improves symptoms and allows patients to reduce oral glucocorticoid use without loss of control of asthma. An earlier la...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publishing
2015-08-01
|
| Colecção: | Therapeutic Advances in Respiratory Disease |
| Acesso em linha: | https://doi.org/10.1177/1753465815581279 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|